Matches in Wikidata for { <http://www.wikidata.org/entity/Q86277822> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q86277822 description "clinical trial" @default.
- Q86277822 description "ensayu clínicu" @default.
- Q86277822 description "klinisch onderzoek" @default.
- Q86277822 description "клінічне випробування" @default.
- Q86277822 description "կլինիկական փորձարկում" @default.
- Q86277822 name "Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events" @default.
- Q86277822 name "Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events" @default.
- Q86277822 type Item @default.
- Q86277822 label "Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events" @default.
- Q86277822 label "Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events" @default.
- Q86277822 prefLabel "Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events" @default.
- Q86277822 prefLabel "Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events" @default.
- Q86277822 P1132 Q86277822-55948C36-7844-4B75-AE7C-463FF1A830F3 @default.
- Q86277822 P1476 Q86277822-4C9C7C02-9A41-41B5-8BB4-E04D6D948620 @default.
- Q86277822 P17 Q86277822-BBA5E00D-9C05-4E80-9FCA-A501D7FDB364 @default.
- Q86277822 P1813 Q86277822-989C27DE-241A-4DDD-9744-29324ADD50E4 @default.
- Q86277822 P3098 Q86277822-7832BE20-0277-4B4F-BC4F-90E7E537889E @default.
- Q86277822 P31 Q86277822-A12299E6-4521-435E-8C01-19A5CB0A888E @default.
- Q86277822 P4135 Q86277822-F488FF04-9925-40E3-BCEA-705941283FAA @default.
- Q86277822 P580 Q86277822-2C08C830-EEE6-42F7-8B82-658FB0F5BB4F @default.
- Q86277822 P582 Q86277822-4ECA73FE-39B2-4412-BCB9-D5C75035CE93 @default.
- Q86277822 P8363 Q86277822-9BB98A45-A9BD-49F6-94CB-6C56931785CD @default.
- Q86277822 P1132 "+100000" @default.
- Q86277822 P1476 "Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events" @default.
- Q86277822 P17 Q142 @default.
- Q86277822 P1813 "CARTABLE" @default.
- Q86277822 P3098 "NCT04279470" @default.
- Q86277822 P31 Q30612 @default.
- Q86277822 P4135 "+100" @default.
- Q86277822 P580 "2019-01-01T00:00:00Z" @default.
- Q86277822 P582 "2025-01-01T00:00:00Z" @default.
- Q86277822 P8363 Q818574 @default.